MAP
Moody Aldrich Partners’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
89,164
+31,323
| +54% | +$438K | 0.24% | 109 |
|
|
2025
Q1 | $780K | Sell |
57,841
-847
| -1% | -$11.4K | 0.16% | 112 |
|
|
2024
Q4 | $1.13M | Buy |
+58,688
| New | +$1.13M | 0.21% | 113 |
|
|
2023
Q3 | – | Sell |
-57,451
| Closed | -$1.37M | – | 216 |
|
|
2023
Q2 | $1.37M | Sell |
57,451
-41,975
| -42% | -$999K | 0.27% | 106 |
|
|
2023
Q1 | $2.53M | Buy |
99,426
+40,515
| +69% | +$1.03M | 0.51% | 76 |
|
|
2022
Q4 | $1.72M | Buy |
+58,911
| New | +$1.72M | 0.35% | 96 |
|